Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19
Publication
, Journal Article
Gupta, A; Chun, HJ
Published in: Frontiers in Immunology
June 23, 2021
Duke Scholars
Published In
Frontiers in Immunology
DOI
EISSN
1664-3224
Publication Date
June 23, 2021
Volume
12
Publisher
Frontiers Media SA
Related Subject Headings
- 3204 Immunology
- 3105 Genetics
- 3101 Biochemistry and cell biology
- 1108 Medical Microbiology
- 1107 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Gupta, A., & Chun, H. J. (2021). Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.693085
Gupta, Akash, and Hyung J. Chun. “Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19.” Frontiers in Immunology 12 (June 23, 2021). https://doi.org/10.3389/fimmu.2021.693085.
Gupta A, Chun HJ. Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19. Frontiers in Immunology. 2021 Jun 23;12.
Gupta, Akash, and Hyung J. Chun. “Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19.” Frontiers in Immunology, vol. 12, Frontiers Media SA, June 2021. Crossref, doi:10.3389/fimmu.2021.693085.
Gupta A, Chun HJ. Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19. Frontiers in Immunology. Frontiers Media SA; 2021 Jun 23;12.
Published In
Frontiers in Immunology
DOI
EISSN
1664-3224
Publication Date
June 23, 2021
Volume
12
Publisher
Frontiers Media SA
Related Subject Headings
- 3204 Immunology
- 3105 Genetics
- 3101 Biochemistry and cell biology
- 1108 Medical Microbiology
- 1107 Immunology